Stakeholders Warn Medicare Payment Proposals For Cell, Gene Therapy Could Hamper Access

 
• By Cathy Kelly
  
Is CMS out of alignment with recent FDA action to promote access to cell and gene therapy? (Shutterstock)

More from Cell & Gene Therapies

More from Medicare